Task: Answer the MCQ question.
Question: Which compound exhibits a 33.794% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a CC(C)C(=O)NNc1ccccc1
b CC(=O)c1cccc(-n2nnnc2SCC(=O)N2CCCC2)c1
c N#C/C(=N\Nc1ccccc1[N+](=O)[O-])C(=N)N1CCCCC1
Answer: c. N#C/C(=N\Nc1ccccc1[N+](=O)[O-])C(=N)N1CCCCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
N#C/C(=N\Nc1ccccc1[N+](=O)[O-])C(=N)N1CCCCC1
N#C/C(=N\Nc1ccccc1[N+](=O)[O-])C(=N)N1CCCCC1
[2-[(2E)-2-(1-cyano-2-imino-2-piperidin-1-ylethylidene)hydrazinyl]phenyl]-oxido-oxoazanium